AML1-ETO can also be mentioned in this Section 3.4, because of its ability to transactivate the expression of KIT in AML cells, by notably mediating extrusion loops, allowing the interactions of KIT promoter and one of its enhancers [65]. The gene discussed is KIT; the disease is acute myeloid leukemia.